Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 12:22 pm Sale | 2025-09-30 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 3,477,227 5.100% | -2,546,000 (-42.27%) | Filing History |
| 2025-11-07 12:14 pm Purchase | 2025-09-30 | 13G | Lantheus Holdings, Inc. LNTH | MORGAN STANLEY MS | 3,777,712 5.600% | 3,777,712 (New Position) | Filing History |
| 2025-11-05 11:40 am Sale | 2025-09-30 | 13G | Lantheus Holdings, Inc. LNTH | FMR LLC | 4,399,524 6.500% | -824,212 (-15.78%) | Filing History |
| 2025-08-14 11:17 am Sale | 2025-06-30 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 6,938,984 10.000% | -16,071 (-0.23%) | Filing History |
| 2025-08-06 12:06 pm Purchase | 2025-06-30 | 13G | Lantheus Holdings, Inc. LNTH | FMR LLC | 5,223,736 7.500% | 5,223,736 (New Position) | Filing History |
| 2025-06-06 11:59 am Purchase | 2025-05-30 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 6,955,055 10.100% | 439,569 (+6.75%) | Filing History |
| 2025-05-14 12:16 pm Purchase | 2025-03-31 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 6,515,486 9.500% | 316,797 (+5.11%) | Filing History |
| 2025-05-08 4:09 pm Purchase | 2025-03-31 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 6,023,227 8.800% | 707,000 (+13.30%) | Filing History |
| 2025-02-14 12:11 pm Purchase | 2024-12-31 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 6,198,689 8.900% | 2,610,118 (+72.73%) | Filing History |
| 2025-02-05 1:10 pm Purchase | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 5,316,227 7.600% | 252,000 (+4.98%) | Filing History |
| 2024-11-14 8:21 pm Purchase | 2024-11-08 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 5,064,227 7.300% | 5,064,227 (New Position) | Filing History |
| 2024-11-14 3:29 pm Sale | 2024-09-30 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 3,588,571 5.200% | -374,035 (-9.44%) | Filing History |
| 2024-03-08 11:22 am Purchase | 2024-03-06 | 13D | Perspective Therapeutics, Inc. CATX | Lantheus Holdings Inc. LNTH | 11,677,339 19.900% | 6,043,104 (+107.26%) | Filing History |
| 2024-02-14 1:18 pm Purchase | 2023-12-31 | 13G | Lantheus Holdings, Inc. LNTH | JANUS HENDERSON GROUP PLC JHG | 3,962,606 5.800% | 3,962,606 (New Position) | Filing History |
| 2024-02-13 5:08 pm Sale | 2023-12-29 | 13G | Lantheus Holdings, Inc. LNTH | VANGUARD GROUP INC | 6,973,141 10.180% | -273,983 (-3.78%) | Filing History |
| 2024-02-01 07:38 am Purchase | 2024-01-22 | 13D | Perspective Therapeutics, Inc. CATX | Lantheus Holdings Inc. LNTH | 5,634,236 10.740% | 5,634,236 (New Position) | Filing History |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | Lantheus Holdings, Inc. LNTH | BlackRock Inc. BLK | 8,600,964 12.600% | 387,244 (+4.71%) | Filing History |
| 2023-02-10 2:11 pm Unchanged | 2022-12-31 | 13G | Lantheus Holdings, Inc. LNTH | BlackRock Inc. BLK | 8,213,720 11.900% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:25 am Sale | 2022-12-30 | 13G | Lantheus Holdings, Inc. LNTH | VANGUARD GROUP INC | 7,247,124 10.530% | -191,600 (-2.58%) | Filing History |
| 2023-01-26 08:52 am Purchase | 2022-12-31 | 13G | Lantheus Holdings, Inc. LNTH | BlackRock Inc. BLK | 8,213,720 11.900% | 10,250 (+0.12%) | Filing History |